Researchers present a potential test to predict a baby’s asthma risk in their first year of life and the preventive treatments that can follow.

Medical Mythbusting Commentary for September 13, 2022

By better predicting asthma risk, preventive treatments could bypass disease development

Lipopolysaccharide-induced interferon response networks at birth are predictive of severe viral lower respiratory infections in the first year of life